Innovative coating for blood vessels reduces rejection of transplanted organs
Researchers have found a way to reduce organ rejection following a transplant by using a special polymer to coat blood vessels on the organ to be transplanted.
Cloud computing support accelerates COVID-19 vaccine improvements
For the last 11 months, UBC biochemistry and molecular biology professor Prof. Leonard Foster and his team have been studying how SARS-CoV-2 – the virus responsible for COVID-19 – attacks the human body, in hopes of developing a more targeted vaccine with fewer side effects.
New algorithm can identify cells that humans can’t
Researchers at the University of British Columbia have developed an algorithm that can accurately identify different types of cells pictured in microscope photos, even when those cells are indistinguishable to the human eye.
The Kastrup Lab receives $2.3m USD to launch 2 new projects treating soldiers suffering from severe, uncontrolled bleeding
The funding will go towards improving platelet blood products and developing a wound dressing called CounterFlow Gauze, both of which are especially relevant to soldiers in combat scenarios.
November 2020: Notes from the CBR Director
Here we are now, almost 23 years since the Krever report, amidst another “unprecedented” public health disaster caused by yet another virus – arguably more menacing than the others, causing world-wide havoc at many levels. As always, in our roles in academia, CBR members are meeting the challenges head-on.
Science Literacy Week 2020: Meet the Blood Cells!
For Science Literacy Week 2020, we invited our audience to #MeetTheBloodCells on social media, from the Excellent Erythrocyte to the Noble Neutrophil.
Joining forces to improve blood research in Canada
Partnership with Canadian Blood Services and UBC’s Centre for Blood Research helps train the next generation of blood scientists.
Nobel Prize Series Introduction: Pomp and Circumstance?
Just like the Oscars (and basically every award), the Nobel Prize is not without its criticisms and controversies.
Fast and Furious: Targeting “nitro(gen) boosts” in a deadly bacterium for next-generation antimicrobials
What if bacteria also had the ability to use nitrogen for a “boost”? Alford et al. recently examined the role of a two-component system called NtrBC in Pseudomonas aeruginosa.
Identifying Patients At Risk of Severe Complications Using Sequencing Technology
Dr. Bob Hancock, UBC Killam professor, will use genomic methods to identify which patients with COVID-19 are at higher risk of developing life-threatening sepsis.